These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16291989)

  • 1. Pharmacotherapy for obesity--promise and uncertainty.
    Yanovski SZ
    N Engl J Med; 2005 Nov; 353(20):2187-9. PubMed ID: 16291989
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacotherapy in the treatment of obesity].
    Hamann A
    MMW Fortschr Med; 2006 Mar; 148(9):36-8. PubMed ID: 16566392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug treatment of obesity].
    Svendsen OL; Toubro S; Breum L; Bruun JM; Astrup AV
    Ugeskr Laeger; 2006 Jan; 168(2):163-7. PubMed ID: 16403342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug treatment of obesity].
    Burniat W
    Rev Med Brux; 2009; 30(2):124-6. PubMed ID: 19517912
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic risk factors, drugs, and obesity.
    Padwal R; Majumdar S
    N Engl J Med; 2006 Mar; 354(9):974-5; author reply. PubMed ID: 16510755
    [No Abstract]   [Full Text] [Related]  

  • 6. [Obesity in adults].
    Suter PM; Kolyvanos NU; Käser L; Vetter W
    Praxis (Bern 1994); 2007 Oct; 96(42):1617-24; quiz 1625-6. PubMed ID: 17974121
    [No Abstract]   [Full Text] [Related]  

  • 7. New options for drug treatment of obesity in patients with Type 2 diabetes.
    Kennedy RL; Khoo EY
    Diabet Med; 2005 Sep; 22 Suppl 4():23-6. PubMed ID: 16109016
    [No Abstract]   [Full Text] [Related]  

  • 8. Current pharmacotherapeutic concepts for the treatment of obesity in adults.
    Idelevich E; Kirch W; Schindler C
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):75-90. PubMed ID: 19144669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacotherapy for weight loss in patients with type 2 diabetes].
    Toubro S
    Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic treatment for obesity. Options for today...and tomorrow.
    Lundquist LM; Sirimaturos M; Cannon E
    Adv Nurse Pract; 2006 Aug; 14(8):31-5, 64. PubMed ID: 16972485
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term medication use and weight loss maintenance: an observational study.
    Womble LG; Wadden TA; Berkowitz RI; Sarwer DB; Rothman RA
    Obes Res; 2001 Oct; 9(10):652-3. PubMed ID: 11595785
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term effects of weight-reducing drugs in hypertensive patients--a survey of a Cochrane review].
    Madsbad S
    Ugeskr Laeger; 2011 Feb; 173(8):564-7. PubMed ID: 21333255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.
    Després JP; Golay A; Sjöström L;
    N Engl J Med; 2005 Nov; 353(20):2121-34. PubMed ID: 16291982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of obesity and depression].
    Rihmer Z; Purebl G; Faludi G; Halmy L
    Neuropsychopharmacol Hung; 2008 Oct; 10(4):183-9. PubMed ID: 19213197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new role of pharmacotherapy for weight reduction in obesity.
    Fernstrom MH; Fernstrom JD
    Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacotherapy of obesity].
    Svendsen OL
    Ugeskr Laeger; 2004 Oct; 166(43):3814-7. PubMed ID: 15544112
    [No Abstract]   [Full Text] [Related]  

  • 17. [New drugs for the treatment of obesity].
    Mustajoki P
    Duodecim; 1999; 115(20):2191, 2193-4. PubMed ID: 11973921
    [No Abstract]   [Full Text] [Related]  

  • 18. Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks.
    Gadde KM; Allison DB
    Circulation; 2006 Aug; 114(9):974-84. PubMed ID: 16940206
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of antiobesity medications in patients with type 2 diabetes mellitus.
    Choussein S; Makri AA; Frangos CC; Petridou ET; Daskalopoulou SS
    Diabetes Obes Metab; 2009 Jul; 11(7):641-64. PubMed ID: 19236442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Weight reduction. Antiobesity drug treatment in type-2 diabetics].
    Verspohl EJ
    Pharm Unserer Zeit; 2002; 31(3):300-7. PubMed ID: 12071127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.